Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jacques Planas, Ana Celma, José Placer, Mercè Cuadras, Lucas Regis, Carlos Gasanz, Enrique Trilla, Carlos Salvador, David Lorente & Juan Morote. (2016) Hormonal response recovery after long-term androgen deprivation therapy in patients with prostate cancer. Scandinavian Journal of Urology 50:6, pages 425-428.
Read now
Read now
Articles from other publishers (9)
Ronald Tutrone, Fred Saad, Daniel J. George, Bertrand Tombal, James L. Bailen, Michael S. Cookson, Daniel R. Saltzstein, Sarah Hanson, Bruce Brown, Sophia Lu, Mark Fallick & Neal D. Shore. (2023) Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study. European Urology Oncology.
Crossref
Crossref
Carsten-Henning Ohlmann, Michelle Jäschke, Peter Jaehnig, Susanne Krege, Jürgen Gschwend, Heidrun Rexer, Kerstin Junker, Roger Zillmann, Christoph Rüssel, Eva Hellmis, Henrik Suttmann, Martin Janssen, Jan Marin, Andreas Hübner, Michael Mathers, Jochen Gleißner, Michael Scheffler, Susan Feyerabend, Jens Telle, Jörg Klier & Michael Stöckle. (2022) LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial. Prostate Cancer and Prostatic Diseases 25:4, pages 778-784.
Crossref
Crossref
Ji Yong Choi & Cheol Young Choi. (2020) Gonadotropin-releasing hormone-independent effects of recombinant vertebrate ancient long opsin in the goldfish Carassius auratus reveal alternative reproduction pathways. Fish Physiology and Biochemistry 46:4, pages 1219-1227.
Crossref
Crossref
Seung Il Jung, Myung Soo Kim, Chang Wook Jeong, Cheol Kwak, Sung Kyu Hong, Seok Ho Kang, Jae Young Joung, Seung Hwan Lee, Seok Joong Yun, Tae-Hwan Kim, Sung Woo Park, Seong Soo Jeon, Minyong Kang, Ji Youl Lee, Byung Ha Chung, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim & Dong Deuk Kwon. (2020) Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting. Investigative and Clinical Urology 61:1, pages 19.
Crossref
Crossref
Bruno Nascimento, Eduardo P. Miranda, Lawrence C. Jenkins, Nicole Benfante, Elizabeth A. Schofield & John P. Mulhall. (2019) Testosterone Recovery Profiles After Cessation of Androgen Deprivation Therapy for Prostate Cancer. The Journal of Sexual Medicine 16:6, pages 872-879.
Crossref
Crossref
Takahiro Inoue, Takashi Mizowaki, Daijiro Kabata, Ayumi Shintani, Naoki Terada, Toshinari Yamasaki, Hiromitsu Negoro, Takashi Kobayashi, Kiyonao Nakamura, Haruo Inokuchi & Osamu Ogawa. (2018) Recovery of Serum Testosterone Levels and Sexual Function in Patients Treated With Short-term Luteinizing Hormone-releasing Hormone Antagonist as a Neoadjuvant Therapy Before External Radiotherapy for Intermediate-risk Prostate Cancer: Preliminary Prospective Study. Clinical Genitourinary Cancer 16:2, pages 135-141.e1.
Crossref
Crossref
Carsten-Henning Ohlmann, Michelle Jäschke, Peter Jaehnig, Susane Krege, Jürgen Gschwend, Heidrun Rexer & Michael Stöckle. (2017) Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled trial. Trials 18:1.
Crossref
Crossref
Tomasz M. Beer, Guy T. Bernstein, John M. Corman, L. Michael Glode, Simon J. Hall, Wayne L. Poll, Paul F. Schellhammer, Lori A. Jones, Yi Xu, Jelle W. Kylstra & Mark W. Frohlich. (2011) Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer. Clinical Cancer Research 17:13, pages 4558-4567.
Crossref
Crossref
Takashi Kobayashi. (2008) Editorial Comment. Journal of Urology 180:4, pages 1443-1444.
Crossref
Crossref